Drug
Tpip F2
Tpip F2: highest development phase Phase 1, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| TPIP F2 NCT07102316 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Tpip F2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.